Ideal for AOD-9604 may fit you if: - You want fat-loss support without raising your growth hormone or IGF-1 - You prefer a gentler, non-hormonal approach and are comfortable with modest effects - Blood sugar and insulin sensitivity are concerns you want to leave undisturbed - You are interested in stacking with a metabolic peptide like MOTS-c for a cellular reset - You do not want to affect appetite or muscle mass Consider alternatives if Tesamorelin may fit you if: - Deep abdominal (visceral) fat is your main target - FDA approval and large clinical-trial evidence matter to you - You want the most clinically validated fat-loss peptide available - You are comfortable raising your own GH and IGF-1 as part of the approach - Liver fat or triglycerides are part of the picture your provider is watching The decision is not really AOD-9604 versus Tesamorelin as better or worse

Methionine, Inositol, and Choline help break down fats and aid in their removal from the liver, potentially promoting a more efficient metabolism
FDAs 2024 evaluation of AOD9604 free base and AOD9604 acetate for possible inclusion on the section 503A bulk drug substances list concluded that the available balance of physicochemical characterization, effectiveness, and safety information weighed against inclusion
People With Early Metabolic Syndrome or Insulin Resistance Though still under investigation, early research suggests 5-Amino-1MQ may benefit those with pre-diabetes or insulin resistance by enhancing glucose utilization and reducing visceral fat but clinical supervision is essential
Discuss all current medications with your independent licensed healthcare provider before starting